NCT07565649

Brief Summary

This study aims to evaluate the clinical impact of the systematic implementation of point-of-care ultrasound (POCUS) in the management of patients with septic shock in the intensive care unit (ICU). Septic shock is associated with high morbidity and mortality, and its management requires timely and accurate hemodynamic assessment. Traditional monitoring methods have limitations in evaluating cardiac function, fluid responsiveness, and tissue perfusion. POCUS provides real-time, bedside, non-invasive assessment that may improve clinical decision-making. This is a retrospective, single-center cohort study comparing two time periods: a pre-implementation cohort (2016-2019) and a post-implementation cohort (2022-2025), excluding the COVID-19 pandemic period. The primary objective is to assess whether the implementation of POCUS is associated with an improvement in early organ dysfunction, measured as the change in SOFA score at 48 hours (delta SOFA). Secondary outcomes include mortality at 28, 60, and 90 days, incidence of acute kidney injury, duration of organ support therapies, and length of ICU and hospital stay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 4, 2026

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

10 years

First QC Date

April 17, 2026

Last Update Submit

April 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in SOFA score at 48 hours (Delta SOFA)

    Difference between the Sequential Organ Failure Assessment (SOFA) score at ICU admission and at 48 hours.

    Baseline (ICU admission) and 48 hours after ICU admission

Secondary Outcomes (10)

  • 28-day mortality

    Up to 28 days after ICU admission

  • 60-day mortality

    Up to 60 days after ICU admission

  • 90-day mortality

    Up to 90 days after ICU admission

  • Incidence of acute kidney injury

    From ICU admission to ICU discharge

  • Vasopressor-free days up to day 28

    From ICU admission to day 28

  • +5 more secondary outcomes

Study Arms (2)

Pre-POCUS Cohort

Patients admitted to the ICU with septic shock between January 2016 and December 2019, before the systematic implementation of point-of-care ultrasound (POCUS).

Post-POCUS Cohort

Patients admitted to the ICU with septic shock between January 2022 and December 2025, after the systematic implementation of point-of-care ultrasound (POCUS).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients admitted to the intensive care unit with septic shock in a tertiary care hospital, identified through retrospective review of electronic medical records.

You may qualify if:

  • Age ≥18 years
  • Admission to the intensive care unit (ICU) with a clinical diagnosis or suspicion of septic shock
  • Microbiological confirmation of infection during clinical course
  • Availability of data required to calculate SOFA score at ICU admission and at 48 hours

You may not qualify if:

  • ICU admissions during the period 2020-2021
  • Readmissions related to the same episode of septic shock
  • Missing data required for SOFA score calculation
  • Patients with limitation of life-sustaining therapies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Universidad de Navarra

Pamplona, Navarre, 31008, Spain

Location

MeSH Terms

Conditions

Shock, SepticSepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Alvaro Casado Iglesias, MD

    Clinica Universidad de Navarra

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2026

First Posted

May 4, 2026

Study Start

January 1, 2016

Primary Completion

December 31, 2025

Study Completion

March 31, 2026

Last Updated

May 4, 2026

Record last verified: 2026-04

Locations